← Open Payments lookup

ADAM SCHMUCKLER: Open Payments

NPI 1902903990 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,262 in 159 payments from 45 companies in 2025. Trend: 2023 $2,575 · 2024 $3,486 · 2025 $4,262

Food & beverage: $4,245Education: $17
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation20$442
PFIZER INC.16$403
AstraZeneca Pharmaceuticals LP14$388
Janssen Biotech, Inc.8$328
BeOne Medicines USA, Inc.6$244
Genentech USA, Inc.7$156
Takeda Pharmaceuticals U.S.A., Inc.6$155
Bayer Healthcare Pharmaceuticals Inc.3$143
Daiichi Sankyo Inc.4$114
E.R. Squibb & Sons, L.L.C.4$113

Products named: TEVIMBRA, RYBREVANT, Enhertu, Nubeqa, PLUVICTO, VPRIV, KIMMTRAK, LYNPARZA.

Industry payments across MD — which companies pay providers there.